#Japan #Tokyo #LG Chem #Hyaluronic Acid #Sinks Healthcare

Strategic Partnership Between Sinks Healthcare and LG Chem

In a significant move towards advancing healthcare in Japan, Sinks Healthcare, a subsidiary of Convano Co., Ltd., has signed a strategic partnership agreement with LG Chem Ltd. The partnership aims to facilitate the approval process for medical-grade hyaluronic acid (HA) products from Japan's Pharmaceuticals and Medical Devices Agency (PMDA).

Background of the Agreement

The decision to enter into this partnership was reached during a board meeting convened on July 31, 2025, where the members voted in favor of the collaboration. Following necessary adjustments, the formal signing of the agreement took place on September 22, 2025, marking the official commencement of cooperative efforts aimed at realizing the shared vision of bringing innovative health solutions to the Japanese market.

LG Chem, headquartered in Seoul, South Korea, is a comprehensive chemical corporation known for its robust global operations across various sectors, including chemicals, advanced materials, and life sciences. The company has a pronounced emphasis on research and development, as well as production capability, both in Korea and abroad. This makes LG Chem a potent partner in the fields of battery materials and pharmaceutical development, fostering innovation through the synergy of chemistry and biotechnology.

To learn more about LG Chem, you can visit their official website: LG Chem.

Timeline of Events

• - Board Resolution Date: July 31, 2025
• - Contract Signing Date: September 22, 2025
• - Business Commencement Date: September 22, 2025

It is important to note that the initially scheduled date of August 29, 2025, was adjusted due to procedural negotiations among involved parties.

Future Prospects

The launch of the medical-grade hyaluronic acid product is forecasted for February 2026. Sinks Healthcare anticipates revenues of around 30 million yen from this new offering. These projections have already been integrated into the consolidated financial forecasts for the fiscal period ending in March 2026, and currently, there are no revisions to the established financial outlook. Any potential developments that may significantly influence investment decisions will be promptly disclosed as necessary.

About Convano Co., Ltd.

Convano Co., Ltd. operates with the mission of creating new value and expanding opportunities, notably through its well-known nail service chain, FASTNAIL, operating nationwide in Japan. Leveraging expertise in digital marketing and AI systems development, the company is actively expanding its business within the beauty and lifestyle sectors. Moreover, Convano is making strides towards establishing itself as a next-generation platformer sourced from Japan through substantial investments in the WEB3 infrastructure space.

Business Focus

• - Operation of the FASTNAIL nail service chain
• - Franchise management
• - Development and sales of various product planning
• - New business systems development
• - Operation of media platforms, including femedia

For more on Convano, you can check out their corporate site: Convano.

About Sinks Healthcare Co., Ltd.

Sinks Healthcare is committed to enhancing patient access to the most advanced beauty medical technology worldwide, with a mission centered around beauty and mental health. The company integrates innovative foreign medical technologies, providing optimized solutions for the Japanese market while prioritizing quality, safety, and speed. Sinks Healthcare also offers marketing research, consulting, and management support services for beauty medical clinics, embracing a comprehensive approach to strategic planning and operational support.

Business Focus

• - Import agency for pharmaceuticals and medical devices
• - Management support and consulting for beauty medical professionals

For additional details, please visit the Sinks Healthcare corporate site: Sinks Healthcare.